Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.13
+0.03 (0.59%)
Jun 9, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22
Drugs for Cancer Targeted Therapy and Immunotherapy
249.01M
Log In
Drugs for Cancer Targeted Therapy and Immunotherapy Growth
1275.13%
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22
China
249.01M
Log In
China Growth
1275.13%
Log In